chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Dizziness
Clinical narrative: dizziness/lightheadedness; increased BP; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 73 year-old female patient received bnt162b2 (BNT162B2), administration date 24Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset Feb2021, outcome "not recovered", described as "dizziness/lightheadedness "; BLOOD PRESSURE INCREASED (non-serious) with onset Feb2021, outcome "recovered", described as "increased BP". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Ophthalmic migraine
Clinical narrative: Optical migraine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from Medical Information Team. The reporter is the patient.  A 67 year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administered in right arm, administration date 04Mar2021 at 01:00 (Lot number: EN6205) at the age of 67 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "Raynaud's phenomenon" (unspecified if ongoing); "Penicillin allergy" (unspecified if ongoing). Concomitant medication(s) included: CALCIUM+D; FLAXSEED OIL NATURE MADE; MAGNESIUM. Vaccination history included: Bnt162b2 (first dose (lot number: EN6201, administration time: 12:45 PM, & vaccine location: left arm)), administration date: 11Feb2021, when the patient was 67 years old, for COVID-19 immunisation.  The following information was reported: OPHTHALMIC MIGRAINE (non-serious) with onset 04Mar2021 02:00, outcome "recovered" (04Mar2021 02:20), described as "Optical migraine". The event "optical migraine" was evaluated at the physician office visit and emergency room visit. Therapeutic measures were taken as a result of ophthalmic migraine. Additional information: The patient received the second dose of the Pfizer COVID vaccine on 04Mar2021 and 1 hour after receiving the vaccine she started to experienced vision changes that lasted about 20 minutes. By the time she gets to the urgent care to have it evaluated, the vision changes had subsided. The patient was concerned and wanted to know if this has happened to anyone else. The patient went to an ophthalmologist and it was determined unrelated to the vaccine and it was optical migraine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccine, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: Tired; Achy; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP).  A 56 year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) (Batch/Lot number: unknown) at the age of 56 years, as dose number unknown, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 02Mar2021, outcome "recovered" (03Mar2021), described as "Tired"; PAIN (non-serious) with onset 02Mar2021, outcome "recovered" (03Mar2021), described as "Achy". Therapeutic measures were taken as a result of fatigue, pain. Additional information: Treatment included ibuprofen (ADVIL). The patient was not diagnosed with COVID-19 prior to vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Experiencing ringing in the ears; This is a spontaneous report received from a contactable reporter (consumer or other non-healthcare professional) from medical information team. The reporter is the patient.  A 64-year-old female patient received bnt162b2 (PFIZER-BIOTECH COVID-19 mRNA VACCINE, solution for injection), administration date Feb2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TINNITUS (non-serious), outcome "unknown", described as "Experiencing ringing in the ears". The event "experiencing ringing in the ears" was evaluated at the physician office visit. Additional information: for about 3 days her ears just blasted her.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Peripheral coldness
Clinical narrative: feel frozen inside; hands and feet were cold; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (002591). The reporter is the patient.  A 74 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING COLD (non-serious), outcome "unknown", described as "feel frozen inside"; PERIPHERAL COLDNESS (non-serious), outcome "unknown", described as "hands and feet were cold".  Additional Information: The patient reported to have been prescribed with dosage of tofacitinib (XELJANZ XR 11mg)  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Sex: F
Vaccine: COVID19
Symptoms: White blood cell count, White blood cell count decreased
Clinical narrative: low white blood cell count; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  An 84 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: WHITE BLOOD CELL COUNT DECREASED (non-serious) with onset Feb2021, described as "low white blood cell count". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site extravasation, Vaccination site pain
Clinical narrative: right arm pain; liquid dripping out of the injection site; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 62 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 17Feb2021 (Lot number: EL3428) at the age of 62 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (at right arm, as dose 1, single), administration date: 27Jan2021, when the patient was 62 years old, for COVID-19 immunisation, reaction(s): "arm pain in his right arm, at the injection site". The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "right arm pain"; VACCINATION SITE EXTRAVASATION (non-serious) with onset 17Feb2021, outcome "unknown", described as "liquid dripping out of the injection site".  Additional information: It was reported that right arm pain was not as severe as her first dose. During the second administration, the person administering the shot was using an auto retractable syringe (which she never used), and he noticed that after the administration there was liquid dripping out of the injection site.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: I am kind of achy, like my back; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), administration date 02Mar2021 (Lot number: EN6205) at the age of 71 years as dose number unknown, single for COVID-19 immunisation. Relevant medical history included: "COVID" (unspecified if ongoing). There were no concomitant medications. The following information was reported: BACK PAIN (non-serious) with onset 03Mar2021, outcome "unknown", described as "I am kind of achy, like my back". Additional information: The patient wanted to know if she could take Ibuprofen. The patient claims she currently have antibodies and does not need convalescent plasma.  No follow-up attempts are needed. No further information is expected.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Listless, Malaise
Clinical narrative: This is a spontaneous report received from a contactable consumer or other non-HCP. An 82-year-old female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# unknown), at the age of 82, single dose, for COVID-19 immunisation. The patient's medical history not reported. There were no concomitant medications. The patient reported malaise/not feeling well, fatigue/it has made her more tired and listlessness/really fatigued and listless; all with outcome of unknown. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Fatigue, Malaise
Clinical narrative: not feeling well; really tired and fatigued; didn't eat anything the day after body just was not up to it; stayed in bed all day/ couldn't get her strength back; This is a spontaneous report received from a contactable consumer.  A 91-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 24Feb2021 (Lot number: EN6202) at the age of 91 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "blood disease" (unspecified if ongoing), notes: on blood thinners. The patient took concomitant medications. The following information was reported: MALAISE (non-serious) with onset 25Feb2021, outcome "unknown", described as "not feeling well"; FATIGUE (non-serious) with onset 25Feb2021, outcome "unknown", described as "really tired and fatigued"; DECREASED APPETITE (non-serious) with onset 25Feb2021, outcome "unknown", described as "didn't eat anything the day after body just was not up to it"; ASTHENIA (non-serious) with onset 25Feb2021, outcome "unknown", described as "stayed in bed all day/ couldn't get her strength back".  Additional information: The reporter mentioned that the patient also has had a blood disease and was on blood thinners. She had underlying conditions, it may have been anemia or a version of that but the reporter knew the patient has had a blood disease and was on a blood thinner and something else. The reporter stated that the lot said ENG202, he thought but the G could be a 6. The reporter didn't know what to do for the patient other than take her to a doctor and it was a headache going down there so he might try to get her to the nearest immediate care place.  No follow up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Tooth extraction
Clinical narrative: I had my tooth removed, what would be called a big teeth on the right, they had to cut it off; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number: EL9269, Expiration Date: 31May2021) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TOOTH EXTRACTION (non-serious), outcome "unknown", described as "I had my tooth removed, what would be called a big teeth on the right, they had to cut it off". Therapeutic measures were taken as a result of tooth extraction.  Additional Information: The patient was now taking an antibiotic for the event and was asking if that would affect for her going to get the second shot.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: soreness in her upper right arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 28Feb2021 (Lot number: EL9266) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "soreness in her upper right arm".  Additional Information: The patient was concerned about having problems in a "spot" that was not where the shot was given. The patient was wondering if it was normal to have soreness or pain on the side other than where the shot was administered and if the cholesterol in the vaccine could raise patient's cholesterol levels.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: muscle aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 02Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYALGIA (non-serious), outcome "unknown", described as "muscle aches".  Additional information: Patient has scheduled cosmetic buttocks tomorrow 04Mar2021 and she wanted to know if it's ok.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue
Clinical narrative: weakness; feeling of worn down; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administration date 26Feb2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ASTHENIA (non-serious), outcome "unknown", described as "weakness"; FATIGUE (non-serious), outcome "unknown", described as "feeling of worn down".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Gingival disorder
Clinical narrative: gum condition; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient (patient's age: 72; unit: unspecified) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: GINGIVAL DISORDER (non-serious), outcome "unknown", described as "gum condition". Additional information: The patient asked if he could take antibiotics after receiving both BNT162B2 doses, said he has gum condition after dentist appointment.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Decreased appetite, Dizziness
Clinical narrative: Dizzy; trying to eat some food but it still not working/ unable to eat; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 03Mar2021 09:15 (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunisation. Relevant medical history included: "high blood pressure" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: DIZZINESS (non-serious) with onset 03Mar2021, outcome "unknown", described as "dizzy"; DECREASED APPETITE (non-serious) with onset 03Mar2021, outcome "unknown", described as "trying to eat some food but it still not working/ unable to eat".  Additional information: It was reported that the shot was making the patient sick. It was also mentioned that the patient "don't do" drugs and all the patient took was "high blood pressure."  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm he got the vaccine injection in became sore; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm, administration date 27Feb2021 (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 28Feb2021, outcome "unknown", described as "Arm he got the vaccine injection in became sore".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Suspected COVID-19
Clinical narrative: Second shot is due and was sent home because of her exposure, HCP told her she had to wait until she gets the second dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SUSPECTED COVID-19 (non-serious), outcome "unknown", described as "Second shot is due and was sent home because of her exposure, HCP told her she had to wait until she gets the second dose".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Pain in extremity
Clinical narrative: little tired; not feeling like herself; a little bit of a sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 25Feb2021 (Lot number: EN6202) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 25Feb2021, outcome "recovered" (26Feb2021), described as "little tired"; FEELING ABNORMAL (non-serious) with onset 25Feb2021, outcome "recovered" (26Feb2021), described as "not feeling like herself"; PAIN IN EXTREMITY (non-serious) with onset 25Feb2021, outcome "recovered" (26Feb2021), described as "a little bit of a sore arm".  Additional information: It was reported that by the end of Friday (26Feb2021) within 24 hours, she was feeling okay and normal.    No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021253394 same reporter and product, similar event; different patient
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper
Clinical narrative: stomach pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ABDOMINAL PAIN UPPER (non-serious), outcome "recovered", described as "stomach pain".  Additional information: It was reported that the event was experienced about 40 hours after receiving the COVID-19 injection but was resolved within 2 hours.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: Vertigo; dizzy; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 62-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in the left arm, administration date 12Feb2021 13:00 (Lot number: EM9809) at the age of 62 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Type II Diabetic", start date: 2011 (ongoing). There were no concomitant medications. The following information was reported: VERTIGO (non-serious) with onset 26Feb2021, outcome "unknown", described as "vertigo"; DIZZINESS (non-serious) with onset 26Feb2021, outcome "unknown", described as "dizzy".  Additional information: The patient reported that the event occurred especially in the morning upon waking. Initial onset was at unknown time when he woke up in the morning and got out of bed and was super dizzy. The patient asked if he should or should not get the second dose of Pfizer COVID-19 vaccine as scheduled relative to the events. The patient has no history of all previous immunisations. The events did not result to an emergency room or physician office visit. He was not hospitalized due to the events.  No follow-up attempts are possible. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Mutism
Clinical narrative: she lost her voice; she just can't talk; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 74 year-old female patient received bnt162b2 (BNT162B2), administration date 01Mar2021 (Lot number: EN6198) at the age of 74 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (First Dose, Lot number: EL9261), for COVID-19 immunization. The following information was reported: APHONIA (non-serious) with onset 02Mar2021, outcome "not recovered", described as "she lost her voice"; MUTISM (non-serious) with onset 02Mar2021, outcome "not recovered", described as "she just can't talk". Additional information: It was reported that the patient had the shot and the first thing she did was she came home and went to bed, she lives by herself. The next day she was trying to sing, and she thought her voice doesn't sound right. She just thought she might better have it recorded, she has no other symptoms, she just can't talk. The patient said she does not know if it began the night of the vaccine on the 01Mar2021 because she came home and went to bed, she did not talk to anyone; she confirmed the first time she noticed it was 02Mar2021. The event was still ongoing and reported that the patient does not talk like this at all. The patient was not sure if it was related to the vaccine, she was not sure she just knew that it came on that quick. She has to say getting the shots could not been more pleasant from the moment she walked in to than when she left. The patient had no investigation assessment. The events were assessed as non-serious by the reporter. The relatedness of BNT162B2 to events/reactions with primary source reporter as the source of assessment and global introspection as method of assessment was unknown. No follow-up attempts are possible. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Slight Soreness of the Arm with first dose; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 25Jan2021 (Lot number: EN5318) at the age of 75 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Chronic Bladder Infections" (ongoing), notes: took no treatment. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 26Jan2021, outcome "recovered" (27Jan2021), described as "Slight Soreness of the Arm with first dose". Therapeutic measures were not taken as a result of pain in extremity.  No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Malaise
Clinical narrative: I am not feeling well today; Light-headed / dizzy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 01Mar2021 (Lot number: EN6205) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset Mar2021, outcome "unknown", described as "Light-headed / dizzy"; MALAISE (non-serious) with onset 03Mar2021, outcome "unknown", described as "I am not feeling well today".  Additional information: The patient was inquiring if it was okay that side effects were experienced a couple of days later; patient thought it (side effects) would show up within the same day.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Joint stiffness
Clinical narrative: knees got so stiff/both her knees have stayed stiff; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 10Feb2021 (Batch/Lot number: unknown) at the age of 66 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Spine Issues", start date: 2003 (unspecified if ongoing); "Fibromyalgia" (unspecified if ongoing), notes: for 30 years; "Knee replacement" (unspecified if ongoing), notes: she had both knees replaced about 5 years ago; "car accident", start date: 2003 (unspecified if ongoing). Concomitant medication(s) included: CBD OIL (ongoing). The following information was reported: JOINT STIFFNESS (non-serious) with onset 10Feb2021, outcome "not recovered", described as "knees got so stiff/both her knees have stayed stiff".  Additional information: Patient said she had been medicating with CBD oil and medical marijuana for the past 3 years. Patient wasn't sure of the lot number and stated it was either E19262, EI9262, or EL9262. Events did not result to physician office and emergency room visit. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and no additional vaccines were administered on same date of the Pfizer Suspect.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Memory impairment
Clinical narrative: forgetting simple things; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MEMORY IMPAIRMENT (non-serious), outcome "unknown", described as "forgetting simple things".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021234124 Same reporter and drug, similar event, different patient
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: Dizziness; Vomiting; Nausea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection) (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "Dizziness"; VOMITING (non-serious), outcome "unknown", described as "Vomiting"; NAUSEA (non-serious), outcome "unknown", described as "Nausea". Additional information: Events occurred 2 days after the vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness at injection site; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A 37 year-old female patient received bnt162b2 (BNT162B2), administered in deltoid right, administration date 14Jan2021 (Lot number: EL0142) at the age of 37 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose, lot no: EH9899, NDC number: 59267100001, Expiry Date: 31Mar2021, intramuscularly at the left deltoid), administration date: 15Dec2020, when the patient was 37 years old, for COVID-19 immunisation, reaction(s): "body ache", "headache", "nausea", "fatigue", "vomiting", "swollen, red, hot painful arm at injection site", "swollen, red, hot painful arm at injection site", "swollen, red, hot painful arm at injection site", "swollen, red, hot painful arm at injection site", "Pain in right hip", "Cellulitis/lefft upper arm cellulitis", "The patient received five times the recommened dosage", "The patient received the unreconstituted dosage", "Photophobia". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 14Jan2021, outcome "recovered", described as "soreness at injection site". Therapeutic measures were taken as a result of vaccination site pain.  Additional information: Patient reported soreness at injection site that evening and took ibuprofen. Reporter checked on patient on 15Jan2021 and patient said she was fine. No further complaints. Reporter followed up this morning 03Mar2021, and patient was still feeling fine and previous AEs have resolved.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Constipation
Clinical narrative: Constipation; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CONSTIPATION (non-serious), outcome "unknown", described as "Constipation".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Sore arm".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Blood oestrogen, Blood test, Electrocardiogram, SARS-CoV-2 test, Somnolence
Clinical narrative: Got the Covid shot and I cannot wake her up, she sleep and sleep; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 93-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), administration date 25Feb2021 (Lot number: EL9267) at the age of 93 years as dose number unknown, single for COVID-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: SOMNOLENCE (non-serious) with onset 2021, outcome "unknown", described as "Got the Covid shot and I cannot wake her up, she sleep and sleep". The event "got the covid shot and i cannot wake her up, she sleep and sleep" was evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of somnolence. Additional information: The patient was the reporter's mother. Concomitant medications included vitamins. The event was described as: "She is just like someone gave her, I don't know like a hallucinogenic, she is just out of it". The patient was tested for COVID in the hospital. The reporter was wondering what to do.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Muscle spasms, Somnolence
Clinical narrative: severe headaches; muscle spasms mainly in her legs; this second one has knocked her on her butt; could hardly keep her eyes open, she laid couch and fell sound asleep/ if she sits down she will fall asleep; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old female patient received bnt162b2 (BNT162B2) (Lot number: EL9267, Expiration Date: 31May2021) as dose 2, single for covid-19 immunisation. Relevant medical history included: "suspected COVID-19", start date: Jan2020 (unspecified if ongoing), notes: doctor said they had a virus of some sort but they did not know what it was. There were no concomitant medications. Vaccination history included: Bnt162b2 (dose 1, single, Lot number: EL9267), for COVID-19 immunisation, reaction(s): "severe headaches", "muscle spasms mainly in her legs", "if she sits down she will fall asleep". The following information was reported: SOMNOLENCE (non-serious) with onset 22Feb2021, outcome "unknown", described as "could hardly keep her eyes open, she laid couch and fell sound asleep/ if she sits down she will fall asleep"; HEADACHE (non-serious), outcome "not recovered", described as "severe headaches"; MUSCLE SPASMS (non-serious), outcome "not recovered", described as "muscle spasms mainly in her legs"; FATIGUE (non-serious), outcome "unknown", described as "this second one has knocked her on her butt".  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, SARS-CoV-2 test
Clinical narrative: my 1st two fingers (like my finger fell asleep) and had very little feeling; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administered in left arm, administration date 13Jan2021 at 10:00 (Lot number: EL0142) at the age of 43 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "known allergies Yes" (unspecified if ongoing). The patient took concomitant medications.  The following information was reported: HYPOAESTHESIA (non-serious), outcome "recovered", described as "my 1st two fingers (like my finger fell asleep) and had very little feeling". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The event experienced by the patient lasted about 2 and 1/2 hours. The patient did not receive other vaccine in four weeks. The patient did not have COVID prior to vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore at injection site; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71 year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 10Feb2021 (Lot number: en5318) at the age of 71 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "sore at injection site".  Additional information: This report was received. The patient was not pregnant at time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient also received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 02Mar2021 at 19:15 (Lot number: en6203) for COVID-9 immunisation and experienced pain, symptoms of flu, muscles and joints sore all over, chills, headache, sore throat, ear ache.  No follow-up attempts are possible; No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: can't stay awake, unable to stay awake; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 26Feb2021 (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation. Relevant medical history included: "Spinal stenosis" (ongoing). Concomitant medication(s) included: NORCO taken for spinal stenosis (ongoing). Vaccination history included: BNT162B2 (DOSE 1, SINGLE), for COVID-19 immunisation, reaction(s): "a little soreness on the arm". The following information was reported: SOMNOLENCE (non-serious), outcome "unknown", described as "can't stay awake, unable to stay awake". The event "can't stay awake, unable to stay awake" was evaluated at the emergency room visit.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: He experienced pain in the arm, at the injection site; This is a spontaneous report received from a contactable reporter (consumer or other non-HCP) from medical information team.  A 42-year-old male patient received bnt162b2 (PFIZER-BIOTECH COVID-19 mRNA VACCINE, solution for injection), administered in arm (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "He experienced pain in the arm, at the injection site".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Patient later states it was less painful than her flu shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (134184). The reporter is the patient.  A 50-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection) (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Lyrica. Vaccination history included: Flu shot, for immunisation, reaction(s): "pain". The following information was reported: PAIN (non-serious), outcome "unknown", described as "Patient later states it was less painful than her flu shot". Additional information: The patient also received the second dose of BNT162B2 and stated that both doses were less painful then the flu shot.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Little soreness in the arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Spinal stenosis" (unspecified if ongoing). Concomitant medication(s) included: NORCO taken for spinal stenosis. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Little soreness in the arm". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness on the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 04Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "soreness on the injection site".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Pain in extremity
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 03Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Mar2021, outcome "unknown", described as "sore arm"; MIGRAINE (non-serious) with onset Mar2021, outcome "unknown", described as "migraine".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Rhinorrhoea
Clinical narrative: cold; sniffing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 12Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASOPHARYNGITIS (non-serious), outcome "not recovered", described as "cold"; RHINORRHOEA (non-serious), outcome "not recovered", described as "sniffing".  Additional information: It was reported that the patient was still sniffing due to the cold that she got over the weekend. The patient was querying on until when she can take the vaccine since there was a scheduled snow for tomorrow and she might not get it tomorrow.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 28Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIARRHOEA (non-serious), outcome "not recovered", described as "Diarrhea".  Additional information: The patient received the first dose about a week ago and experienced diarrhea for a week now (at the time of report) after receiving the dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site discomfort
Clinical narrative: mild discomfort at injection site; mild tiredness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 06Feb2021 08:15 (Lot number: EL9265) at the age of 73 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FISH OIL (ongoing); GLUCOSAMINE (ongoing); LISINOPRIL (ongoing). Vaccination history included: Bnt162b2 (1st dose , Administration time: 08:30, Lot number: EL3248, Vaccine location: Arm left), administration date: 16Jan2021, when the patient was 73 years old, for COVID-19 immunisation, reaction(s): "Very light soreness at injection site", "discomfort at injection site". The following information was reported: VACCINATION SITE DISCOMFORT (non-serious), outcome "unknown", described as "mild discomfort at injection site"; FATIGUE (non-serious), outcome "unknown", described as "mild tiredness".  Additional information: The patient had not received any other vaccines within 4 weeks prior vaccination and had no additional vaccines administered on same day.  No follow-up attempts are possible. No further information is expected.